In gastric cancer cells, oxymatrine decreased the proliferation and invasion of gastric cells by inhibiting the EGFR/Cyclin D1/CDK4/6, EGFR/Akt, and MEK-1/ERK1/2/MMP2 pathways by inhibiting EGFRp-Tyr845. This evidence concerns the gene EGFR and gastric cancer.